EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 127 days ( -10.77 % )
Last Price $2.88 0 %
High/ Low $2.88 - $2.88 0%
Chg 7 Days N/A $2.88 $2.88
Chg 30 Days 18.03 % $2.44 $2.88
Chg 12 mos -61.60 % $7.50 $2.88
Trend - 3 mos 23.20 % Width: 44.08 %
Trend - 12 mos -57.90 % Width: 319.94 %
Pred. range - 3 mos $2.93 - $4.22 1.66 % - 46.48 %
Pred. range - 12 mos N/A - $1.48 -100.00 % - -48.62 %
Short MA avg 3 mos Sell May 30, 2024 - 21 days
Long MA avg 3 mos Buy May 14, 2024 - 32 days
Short/Long MA avg 3 mos Buy May 14, 2024 - 32 days
Short MA avg 12 mos Sell May 30, 2024 - 21 days
Long MA avg 12 mos Buy May 02, 2024 - 40 days
Short/Long MA avg 12 mos Buy Apr 01, 2024 - 63 days
Pivot Short Sell Jun 26, 2024 - 3 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Idorsia Ltd

Idorsia Ltd Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia Ltd has a collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds o... IDRSF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT